Seeking Alpha

Ironwood Pharmaceuticals (IRWD +0.9%) gains on an upgrade to Neutral today from Wedbush. The...

Ironwood Pharmaceuticals (IRWD +0.9%) gains on an upgrade to Neutral today from Wedbush. The firm notes that early script data for Q1 suggests strong week-over-week Linzess growth, which, if sustained, would see Q1 and FY13 end-user demand well ahead of initial estimates.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)